The Novo Nordisk Investigator Sponsored Studies (ISS) Program will accept submissions within our current scientific focus areas as noted below. This is a competitive process. Incomplete submissions or protocols that are not within the scope of these focus areas/have low relevance to the therapeutic area may be rejected without further review. Submissions will be reviewed by relevant Novo Nordisk teams. Decisions will be made based on scientific merit and strategic fit. Please review the submission requirements.  The program requests that investigators specify how they will support enrollment of diverse populations in the study.

At Novo Nordisk, we are driven by curiosity. The topics outlined below are intended to provide a general context and not direction. Proposals may include topics beyond those listed here.

Obesity-related complications

  • Women’s health (incl. menopause, PCOS, infertility etc)
  • Male infertility
  • Cancer
  • Skin disorders
  • Musculoskeletal disorders

Addictive behaviours and eating disorders

  • Alcohol use disorder
  • Nicotine addiction

Mechanistic studies

  • Appetite and eating behaviours incl. food noise

Obesity and CVD

  • Atrial fibrillation
  • Heart failure

Obesity and liver disease

Adolescent obesity

Clinical experience

  • Application form.
  • Investigator Curriculum Vitae (signed and dated within the last year)
  • Active medical license (e.g., if requesting study drug)
  • Conflict of Interest form